These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28667074)

  • 41. Cells Lacking the
    Oser MG; Fonseca R; Chakraborty AA; Brough R; Spektor A; Jennings RB; Flaifel A; Novak JS; Gulati A; Buss E; Younger ST; McBrayer SK; Cowley GS; Bonal DM; Nguyen QD; Brulle-Soumare L; Taylor P; Cairo S; Ryan CJ; Pease EJ; Maratea K; Travers J; Root DE; Signoretti S; Pellman D; Ashton S; Lord CJ; Barry ST; Kaelin WG
    Cancer Discov; 2019 Feb; 9(2):230-247. PubMed ID: 30373918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
    Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
    Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
    Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
    Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.
    Ma LY; Zheng YC; Wang SQ; Wang B; Wang ZR; Pang LP; Zhang M; Wang JW; Ding L; Li J; Wang C; Hu B; Liu Y; Zhang XD; Wang JJ; Wang ZJ; Zhao W; Liu HM
    J Med Chem; 2015 Feb; 58(4):1705-16. PubMed ID: 25610955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.
    Tenjin Y; Matsuura K; Kudoh S; Usuki S; Yamada T; Matsuo A; Sato Y; Saito H; Fujino K; Wakimoto J; Ichimura T; Kohrogi H; Sakagami T; Niwa H; Ito T
    Lab Invest; 2020 Dec; 100(12):1575-1588. PubMed ID: 32801334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
    Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
    Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.
    Saito S; Kikuchi J; Koyama D; Sato S; Koyama H; Osada N; Kuroda Y; Akahane K; Inukai T; Umehara T; Furukawa Y
    Clin Cancer Res; 2019 Mar; 25(5):1601-1611. PubMed ID: 30518632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular mechanisms of bleeding disorderassociated GFI1B
    van Oorschot R; Hansen M; Koornneef JM; Marneth AE; Bergevoet SM; van Bergen MGJM; van Alphen FPJ; van der Zwaan C; Martens JHA; Vermeulen M; Jansen PWTC; Baltissen MPA; Gorkom BAPL; Janssen H; Jansen JH; von Lindern M; Meijer AB; van den Akker E; van der Reijden BA
    Haematologica; 2019 Jul; 104(7):1460-1472. PubMed ID: 30655368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models.
    Sun D; Nikonova AS; Zhang P; Deneka AY; Fitzgerald ME; Michael RE; Lee L; Lilly AC; Fisher SL; Phillips AJ; Nasveschuk CG; Proia DA; Tu Z; Golemis EA
    Mol Cancer Ther; 2021 Aug; 20(8):1367-1377. PubMed ID: 34045230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears.
    Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D
    Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer.
    Giffin MJ; Cooke K; Lobenhofer EK; Estrada J; Zhan J; Deegen P; Thomas M; Murawsky CM; Werner J; Liu S; Lee F; Homann O; Friedrich M; Pearson JT; Raum T; Yang Y; Caenepeel S; Stevens J; Beltran PJ; Canon J; Coxon A; Bailis JM; Hughes PE
    Clin Cancer Res; 2021 Mar; 27(5):1526-1537. PubMed ID: 33203642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
    Ferrari-Amorotti G; Chiodoni C; Shen F; Cattelani S; Soliera AR; Manzotti G; Grisendi G; Dominici M; Rivasi F; Colombo MP; Fatatis A; Calabretta B
    Neoplasia; 2014 Dec; 16(12):1047-58. PubMed ID: 25499218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
    Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
    Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
    [No Abstract]   [Full Text] [Related]  

  • 55. EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest.
    Ishigaki H; Minami T; Morimura O; Kitai H; Horio D; Koda Y; Fujimoto E; Negi Y; Nakajima Y; Niki M; Kanemura S; Shibata E; Mikami K; Takahashi R; Yokoi T; Kuribayashi K; Kijima T
    Biochem Biophys Res Commun; 2019 Nov; 519(4):846-853. PubMed ID: 31558317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells.
    Pettersson HM; Pietras A; Munksgaard Persson M; Karlsson J; Johansson L; Shoshan MC; Påhlman S
    Mol Cancer Ther; 2009 Jan; 8(1):160-70. PubMed ID: 19139125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.
    Ami N; Koga K; Fushiki H; Ueno Y; Ogino Y; Ohta H
    J Pharmacol Sci; 2011; 116(1):81-8. PubMed ID: 21512307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.
    Wang X; Zhang C; Zhang X; Yan J; Wang J; Jiang Q; Zhao L; Zhao D; Cheng M
    Eur J Med Chem; 2020 May; 194():112243. PubMed ID: 32229389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
    Johnson SS; Liu D; Ewald JT; Robles-Planells C; Pulliam C; Christensen KA; Bayanbold K; Wels BR; Solst SR; O'Dorisio MS; Menda Y; Spitz DR; Fath MA
    Cancer Biol Ther; 2024 Dec; 25(1):2382524. PubMed ID: 39054566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.
    Hoang N; Zhang X; Zhang C; Vo V; Leng F; Saxena L; Yin F; Lu F; Zheng G; Bhowmik P; Zhang H
    Bioorg Med Chem; 2018 May; 26(8):1523-1537. PubMed ID: 29439916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.